156 related articles for article (PubMed ID: 37269332)
1. Epithelioid glioblastoma diagnosed 70 years after craniofacial radiotherapy.
Bugdadi A; Cherif MA; Loganadane G; Brugières P; Marniche A; Itti E; Belkacemi Y; Tauziède-Espariat A; Palfi S; Senova S
Acta Neurochir (Wien); 2023 Oct; 165(10):2769-2774. PubMed ID: 37269332
[TBL] [Abstract][Full Text] [Related]
2. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
[TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery and interstitial brachytherapy for glial neoplasms.
McDermott MW; Berger MS; Kunwar S; Parsa AT; Sneed PK; Larson DA
J Neurooncol; 2004; 69(1-3):83-100. PubMed ID: 15527082
[TBL] [Abstract][Full Text] [Related]
5. Brachytherapy for malignant recurrent and untreated gliomas.
Hitchon PW; VanGilder JC; Wen BC; Jani S
Stereotact Funct Neurosurg; 1992; 59(1-4):174-8. PubMed ID: 1338232
[TBL] [Abstract][Full Text] [Related]
6. Effects of iodine-125 brachytherapy on the proliferative capacity and histopathological features of glioblastoma recurring after initial therapy.
Siddiqi SN; Provias J; Laperriere N; Bernstein M
Neurosurgery; 1997 May; 40(5):910-7; discussion 917-8. PubMed ID: 9149248
[TBL] [Abstract][Full Text] [Related]
7. Assessment of therapeutic outcome and role of reirradiation in patients with radiation-induced glioma.
Ohno M; Miyakita Y; Takahashi M; Yanagisawa S; Tamura Y; Kawauchi D; Kikuchi M; Igaki H; Yoshida A; Satomi K; Matsushita Y; Ichimura K; Narita Y
Radiat Oncol; 2022 May; 17(1):85. PubMed ID: 35505351
[TBL] [Abstract][Full Text] [Related]
8. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.
Kleinberg LR; Weingart J; Burger P; Carson K; Grossman SA; Li K; Olivi A; Wharam MD; Brem H
Cancer Invest; 2004; 22(1):1-9. PubMed ID: 15069758
[TBL] [Abstract][Full Text] [Related]
9. What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy?
Koot RW; Habraken JB; Hulshof MC; Paans AM; Bosch DA; Pruim J
Acta Neurochir (Wien); 2008 Apr; 150(4):345-9. PubMed ID: 18278573
[TBL] [Abstract][Full Text] [Related]
10. Interstitial brachytherapy procedures for brain tumors.
Sneed PK; McDermott MW; Gutin PH
Semin Surg Oncol; 1997; 13(3):157-66. PubMed ID: 9143053
[TBL] [Abstract][Full Text] [Related]
11. [Malignant gliomas--radiotherapy].
Schratter-Sehn A
Wien Med Wochenschr; 2006 Jun; 156(11-12):342-5. PubMed ID: 16944365
[TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: a prospective mono-institutional Italian experience.
Gobitti C; Borsatti E; Arcicasa M; Roncadin M; Franchin G; Minatel E; Skrap M; Zanotti B; Tuniz F; Cimitan M; Capra E; Drigo A; Trovò MG
Tumori; 2011; 97(5):614-9. PubMed ID: 22158493
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and therapeutic strategies of radiation-induced glioma: case series and comprehensive literature review.
Onishi S; Yamasaki F; Amatya VJ; Takayasu T; Yonezawa U; Taguchi A; Ohba S; Takeshima Y; Horie N; Sugiyama K
J Neurooncol; 2022 Sep; 159(3):531-538. PubMed ID: 35922583
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
[TBL] [Abstract][Full Text] [Related]
15. Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas.
Fabrini MG; Perrone F; De Franco L; Pasqualetti F; Grespi S; Vannozzi R; Cionini L
Strahlenther Onkol; 2009 Aug; 185(8):524-9. PubMed ID: 19652936
[TBL] [Abstract][Full Text] [Related]
16. Coincidence vs cause: cure in three glioblastoma patients treated with brachytherapy.
Dehdashti AR; Sharma S; Laperriere N; Bernstein M
Can J Neurol Sci; 2007 Aug; 34(3):339-42. PubMed ID: 17803034
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
18. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources.
Gutin PH; Leibel SA; Wara WM; Choucair A; Levin VA; Philips TL; Silver P; Da Silva V; Edwards MS; Davis RL
J Neurosurg; 1987 Dec; 67(6):864-73. PubMed ID: 3316532
[TBL] [Abstract][Full Text] [Related]
19. High activity iodine-125 interstitial implant for gliomas.
Scharfen CO; Sneed PK; Wara WM; Larson DA; Phillips TL; Prados MD; Weaver KA; Malec M; Acord P; Lamborn KR
Int J Radiat Oncol Biol Phys; 1992; 24(4):583-91. PubMed ID: 1429079
[TBL] [Abstract][Full Text] [Related]
20. Contemporary approaches to the treatment of malignant gliomas with radiation therapy.
Leibel SA; Scott CB; Loeffler JS
Semin Oncol; 1994 Apr; 21(2):198-219. PubMed ID: 8153665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
